Redhill Capital is an early-stage venture capital firm based in Guangzhou, China, founded in 2018. The company specializes in investments within the medical industry, focusing on sectors such as medical devices, healthcare, and medical technology. Redhill Capital aims to support innovative companies in these areas, providing them with the necessary resources to grow and succeed in the competitive healthcare landscape.
Redhill Capital is a venture capital firm focusing on the medical industry
16 past transactions
Xianwei Medical
Angel Round in 2023
Xianwei Medical is a manufacturer of ophthalmic surgical robots. It focuses on the field of ophthalmic surgical robots, promoting the product finalization and inspection of the third-generation ophthalmic surgical robots while also starting the medical treatment of other product pipelines under research, such as dry eye treatment equipment.
Precision Autoimmune Therapeutics
Venture Round in 2022
Precision Autoimmune Therapeutics is a clinical-stage innovative drug development company focused on precision therapeutics for patients with autoimmune and inflammatory diseases.
Metanovas develops nutraceutical and cosmeceutical products with revolutionary AI technology. The company's product pipeline includes pharmaceuticals, nutritional supplements, functional foods, and cosmetics, providing patients and consumers with better goods. Metanovas alters how science and AI are used to generate health products.
Xinji Pharmaceuticals is mainly engaged in the R&D of new drug preparations and drug release systems. The company is especially involved in the application and promotion of drug-controlled release, sustained release, and targeted drug release technologies in the industrialization of biomedicine.
Juventas is a provider and developer of innovative immune cell therapeutic drugs. The company's first investigational new drug application for the cell therapeutic product CNCT19 has been officially accepted by the National Medical Products Administration. Comprehensive product pipelines will be developed and promoted constantly to provide effective treatment for malignant hematological neoplasms such as leukemia and lymphoma.
Vistel is a technology-based firm that focuses on the use of artificial intelligence (AI) in the medical field. Vistel was founded in 2016 by Sun Yuhui and Ding Dayong.
Vibrant
Funding Round in 2020
Vibrant develops an AI drug development platform to focus on building immune system-related drug pipelines. The company will use artificial intelligence algorithms to accelerate the efficiency of drug development in various aspects such as target discovery, drug design, and drug efficacy evaluation; at the same time, the company expects to continuously improve the success rate of drug development through sustainable data accumulation and algorithm optimization. It was founded and headed by Dr. Wang Luquan and is based in Guangzhou, Guangdong, China.
GenAssist Therapeutics develops gene therapy drugs using base editing technology, which is advantageous in the field of DMD treatment. Founded in 2020, GenAssist was founded by outstanding scientists and industry experts in July 2020. They are committed to the development of gene editing drugs for a variety of genetic diseases.
Cofoe is a medical device company that provides medical, and health products, and one-stop solutions. Their one-stop solution includes healthcare monitoring, rehabilitation aids, respiratory support, traditional Chinese medicine, medical care, and hearing solutions. Cofoe's brands include Jianer Hearing, which offers comprehensive hearing solutions, Good Nurse Medical Devices, which specializes in the omnichannel retail operation and management of medical devices, Keyuan Medica, which creates a one-stop medical device supply chain platform, and Youngleda, which specializes in the development and service of portable oxygen generators and consumables.
Changzhou Zhishan Medical Technology Co., Ltd. was established in May 2017. It was founded by domestic and international medical experts and senior medical equipment practitioners. It is the first high-tech company in China focusing on diabetes and weight loss. The company is headquartered in the beautiful West Taihu Hi-Tech Industrial Park in Changzhou. The factory has established a 100,000-level purification workshop and established a research and development center in Shanghai Zhangjiang - Shanghai Panda Medical Technology Co., Ltd. Zhishan Medical is engaged in the research and development and industrialization of non-invasive medical devices.
Mingyitang Hospital
Series A in 2018
Mingyitang Hospital is a traditional medicine clinic operator.
Juventas is a provider and developer of innovative immune cell therapeutic drugs. The company's first investigational new drug application for the cell therapeutic product CNCT19 has been officially accepted by the National Medical Products Administration. Comprehensive product pipelines will be developed and promoted constantly to provide effective treatment for malignant hematological neoplasms such as leukemia and lymphoma.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.